Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             132 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute effects of whole-body vibration training on neuromuscular performance and mobility in hypoxia and normoxia in persons with multiple sclerosis: A crossover study Andreu, Luis

37 C p.
artikel
2 Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients Bianco, Assunta

37 C p.
artikel
3 A Multicenter International Study to Evaluate Different Aspects of Relationship Between MS and Pregnancy Altintas, Ayse

37 C p.
artikel
4 Animal Fat Plus Hydrogenated Fat in Association with Increased Odds of Neuromyelitis Optica Spectrum Disorder Rezaeimanesh, Nasim

37 C p.
artikel
5 An Increase in the Prevalence of Multiple Sclerosis Has Moved Kuwait to a High-Risk Zone Alroughani, Raed

37 C p.
artikel
6 An uncommon neurological manifestation of chronic lymphocytic leukemia: Longitudinally extensive transverse myelitis Akdogan, Ozlem

37 C p.
artikel
7 Assessment of Bone Mineral Density at the Distal Radius in Women with Multiple Sclerosis Abna, Zohreh

37 C p.
artikel
8 Assessment of the Quality of Life of Multiple Sclerosis Patients' Caregivers in Saudi Arabia Algahtani, Hussein

37 C p.
artikel
9 Assessment Quality of Life in Multiple Sclerosis Iraqi Patients and its Relation to Patients Factors Almahdawi, Akram

37 C p.
artikel
10 B Cell Over Population Following Alemtuzumab Therapy in a Multiple Sclerosis Patient Mashgari, Shaima Nasser Al

37 C p.
artikel
11 B Cell-Related Chemokine (CXCL13) in CSF is Correlated with the Intrathecal Humoral Immune Response in Patients with Multiple Sclerosis Feki, Sawsan

37 C p.
artikel
12 Brain MRI Differences Between MOG Antibody Disease and AQP4 NMOSD Salama, Sara

37 C p.
artikel
13 Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS Marstrand, Lisbet

37 C p.
artikel
14 Budget Impact Analysis of Cladribine Tablets in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients in Kingdom of Saudi Arabia Bohlega, Saeed Abdullah

37 C p.
artikel
15 Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study Ferraro, Diana

37 C p.
artikel
16 Cladribine Tablets Are a Cost-Effective and Cost-Saving Treatment Strategy for High Disease Activity Relapsing Multiple Sclerosis Patients in Iran Ayati, Nayyereh

37 C p.
artikel
17 Clinical and radiological findings of facial paralysis in multiple sclerosis Di Stadio, Arianna

37 C p.
artikel
18 Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis Erdal, Julie Laub

37 C p.
artikel
19 Clinical observation during alemtuzumab administration Allen, Christopher M

37 C p.
artikel
20 Combined Use of Clinical, Lesion Topography, and Thalamic Volume Helps Differentiating Multiple Sclerosis from its Mimickers Metwally, Hussein Mohammad

37 C p.
artikel
21 Concurrence of Multiple Sclerosis, Oligodendroglioma, and Autosomal Recessive Cerebellar Ataxia with Spasticity in the Same Patient: A Challenging Diagnosis Algahtani, Hussein

37 C p.
artikel
22 Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward Fitzgerald, Kathryn C.

37 C p.
artikel
23 Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines Yamout, B.

37 C p.
artikel
24 Correlation between Central Nervous System Damage and Clinical Disability in a Sample of Egyptian Multiple Sclerosis Patients Aboulwafa, Mohammad

37 C p.
artikel
25 Correlation between EDSS scores and cervical spinal cord atrophy at 3T MRI in multiple sclerosis: A systematic review and meta-analysis Song, Xiaodong

37 C p.
artikel
26 CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis Pietroboni, Anna M.

37 C p.
artikel
27 Demographic and Clinical Characteristics of MS Patients Concomitant with Psoriasis: Lower Relapses, Lower Disability Navardi, Samira

37 C p.
artikel
28 Demographic, Clinical and Paraclinical Characteristics of Multiple Sclerosis Mimickers Among a Sample of Egyptian Patients Atallah, Mohammad

37 C p.
artikel
29 Determining Factors of Self-Esteem in Patients with Multiple Sclerosis Mrabet, Saloua

37 C p.
artikel
30 Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases Wildner, Paula

37 C p.
artikel
31 Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis Holm Hansen, Rikke

37 C p.
artikel
32 Distribution of Cervical Spinal Cord Lesions Among a Sample of Egyptian MS Patients Talaat, Farouk

37 C p.
artikel
33 Does MRZ Reaction Have a Real Significance in the Diagnosis of Multiple Sclerosis? Hradilek, Pavel

37 C p.
artikel
34 Do people with multiple sclerosis want to discuss their long-term prognosis? A nationwide study in Argentina Carnero Contentti, Edgar

37 C p.
artikel
35 Economic Burden of Multiple Sclerosis in Egypt: A Societal Perspective Zakaria, Magd

37 C p.
artikel
36 Economic Sanctions Could Endanger the Health of MS Patients Eskandarieh, Sharareh

37 C p.
artikel
37 Effect of Smoking on Multiple Sclerosis Related Dysphagia Aly, Nahla Aly Merghany

37 C p.
artikel
38 Effects of aging on finger movements in multiple sclerosis Signori, Alessio

37 C p.
artikel
39 Effects of inspiratory muscle training in advanced multiple sclerosis Huang, Min H

37 C p.
artikel
40 Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-Modifying Therapies (1-Year Interim Results) Vermersch, Patrick

37 C p.
artikel
41 Efficacy and Safety of Satralizumab for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder: A Pooled Analysis from Two Phase 3 Clinical Trials De Seze, Jerome

37 C p.
artikel
42 Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis Over 48 Weeks: A Randomized, Placebo-Controlled, Phase 2 Study Montalban, Xavier

37 C p.
artikel
43 Efficacy of a Fourth Alemtuzumab Course in RRMS Patients from CARE-MS II Who Experienced Disease Activity After Three Prior Courses Alroughani, Raed

37 C p.
artikel
44 Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) Bennett, Jeffrey L.

37 C p.
artikel
45 Efficacy of Satralizumab (SA237) As Add-on Therapy in Pre-Specified Additional Analyses of Sakurasky, a Double-Blind Placebo-Controlled Phase 3 Study in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) Yamamura, Takashi

37 C p.
artikel
46 Efficacy of Subcutaneous Interferon Β-1a in Patients with a First Clinical Demyelinating Event in REFLEX is Maintained After Application of the 2017 McDonald Criteria Freedman, Mark S

37 C p.
artikel
47 Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy Hoshino, Hiroki

37 C p.
artikel
48 Epidemiology of MS in Tehran Province, Iran: A Population- Based Study Eskandarieh, Sharareh

37 C p.
artikel
49 Epidemiology of Neuromyelitis Optica Spectrum Disorders Patients in Kuwait Ahmed, Samar Farouk

37 C p.
artikel
50 Evaluating functional electrical stimulation (FES) cycling on cardiovascular, musculoskeletal and functional outcomes in adults with multiple sclerosis and mobility impairment: A systematic review Scally, Jennifer B.

37 C p.
artikel
51 Evaluation of Glucose-6-Phosphate Dehydrogenase Serum Level in Multiple Sclerosis and Neuromyelitis Optica Patients Rezvani,

37 C p.
artikel
52 Expert Opinion on the Use of Cladribine Tablets in Clinical Practice for the Treatment of Relapsing Multiple Sclerosis Sørensen, Per Soelberg

37 C p.
artikel
53 Extensive linear scleroderma en coup de sabre with exertion-induced hemiplegic migraine Martins, Rita

37 C p.
artikel
54 False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm Pitteri, Marco

37 C p.
artikel
55 Family Planning Decision Making is Affected in People with Multiple Sclerosis Lavorgna, Luigi

37 C p.
artikel
56 Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience from Saudi Arabia Algahtani, Hussein

37 C p.
artikel
57 Functional and Dysfunctional Impulsivity in Relapsing Multiple Sclerosis Ellouze, Ahmed Slim

37 C p.
artikel
58 Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis Khayambashi, Shahin

37 C p.
artikel
59 HA280 immunoadsorption, an alternative treatment for neuromyelitis optica spectrum disorders? Liu, Shuangxi

37 C p.
artikel
60 Handedness and potential implications for neurorehabilitation in multiple sclerosis Shirani, Afsaneh

37 C p.
artikel
61 Headache Prevalence in Multiple Sclerosis at Al-Azhar Multiple Sclerosis Unit Essmat, Ahmed

37 C p.
artikel
62 Improvements Across Functional Systems Are Maintained Regardless of Early VS Late Confirmed Disability Improvement: CARE-MS 6-Year Follow-Up Alroughani, Raed

37 C p.
artikel
63 Incidence and Prevalence of Multiple Sclerosis in the Sultanate of Oman: A Hospital Based Study Senani, Marwa Al

37 C p.
artikel
64 Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study Persson, Rebecca

37 C p.
artikel
65 Independent outdoor mobility of persons with multiple sclerosis – A systematic review van der Feen, F.E.

37 C p.
artikel
66 Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy Munger, Kathleen C.

37 C p.
artikel
67 Insulin Resistance is Related with Cognition Impairment in Multiple Sclerosis Patients Khalili, Mohammad

37 C p.
artikel
68 Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity Juto, Alexander

37 C p.
artikel
69 IRAK1 polymorphisms are associated with susceptibility to neuromyelitis optica spectrum disorder Shi, Ziyan

37 C p.
artikel
70 Is a Higher Dietary Intake of Vitamin E Related to Lower Odds of Neuromyelitis Optica Spectrum Disorder? Rezaeimanesh, Nasim

37 C p.
artikel
71 “Is this new medicine going to help me walk again?” Levy, Michael

37 C p.
artikel
72 Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets in the CLARITY and CLARITY Extension Studies Giovanonni, Gavin

37 C p.
artikel
73 Long Term Effectiveness of Cladribine in Patients Enrolled in the CLARITY Trial: Real World Experience from the Lebanese Cohort Yamout, B.

37 C p.
artikel
74 Long-Term Reduction of Relapse Rate and Confirmed Disability Progression After 6 Years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis Gouider, Riadh

37 C p.
artikel
75 Long Term, Registry-Based, Prospective, Post-Authorization Safety Study Evaluating Adverse Events of Special Interest in Patients with Highly Active Relapsing Multiple Sclerosis Newly Started on Cladribine Tablets − CLARION Butzkueven, Helmut

37 C p.
artikel
76 Motor Skill Acquisition Through Virtual Reality in People with Multiple Sclerosis: The Impact of Cognitive Function and Related Biomarkers Al-Sharman, Alham Jehad

37 C p.
artikel
77 Multiple Sclerosis in a Human T-Lymphotropic Virus I (HTLV-I) Infected Patient: Could HTLV-I Be a Viral Trigger for Multiple Sclerosis? Saeidi, Morteza

37 C p.
artikel
78 Multiple Sclerosis in Kazakhstan Aksholpan, Sharapkhanova

37 C p.
artikel
79 Neuromyelitis Optica: A Pilot Study of Clinical Presentation and Status of Serological BiomarkersNMOIgG, AQP4 Among Patients Admitted to a Tertiary Centre in NCNS Sudan Ibrahim, Etedal Ahmed Abuelbasher

37 C p.
artikel
80 Neuromyelitis optica spectrum disorder after treatment with pembrolizumab Shimada, Tomoyo

37 C p.
artikel
81 Neuromyelitis Optica Spectrum Disorders in Arabian Gulf (NMOAG): A Newly Established Registry Shosha, Eslam

37 C p.
artikel
82 No Effect on Infant Birth Weight and Head Circumference After Exposure to Interferon Beta Prior to Or During Pregnancy: A Register-Based Cohort Study in Finland and Sweden Among Women with Multiple Sclerosis Vattulainen, Pia

37 C p.
artikel
83 “No Evidence of Disease Activity”: Is it An Aspirational Therapeutic Goal in MS? Najjar, Mayssam El

37 C p.
artikel
84 Novel Imaging Techniques in Detection of Progressive Multiple Sclerosis Essmat, Ahmed

37 C p.
artikel
85 Osteoporosis in Multiple Sclerosis: The Bystander Effect Mir, Ruqqia

37 C p.
artikel
86 Patients’ expectations of autologous hematopoietic stem cell transplantation as a treatment for MS De Kleermaeker, Floriaan G.C.M.

37 C p.
artikel
87 Patterns of Complementary and Alternative Medicine Use Among Adult Patients with Multiple Sclerosis: A Cross-Sectional Study Alnahdi, Muhannad Abdulaziz

37 C p.
artikel
88 Phenotepic Features of Multiple Sclerosis in the Kazakh Population Aksholpan, Sharapkhanova

37 C p.
artikel
89 Physical activity interventions can improve emotion regulation and dimensions of empathy in persons with multiple sclerosis: An exploratory study Sadeghi Bahmani, Dena

37 C p.
artikel
90 Physical disability and personality traits in multiple sclerosis Estrada-López, Mar

37 C p.
artikel
91 Physician referral improves adherence to the physical activity guidelines for adults with MS: A randomized controlled trial Canning, Karissa L.

37 C p.
artikel
92 Potential Role of High Omega6 to Omega3 Fatty Acids Ratio in Increasing Odds of Neuromyelitis Optica Spectrum Disorder Rezaeimanesh, Nasim

37 C p.
artikel
93 Pregnancy Outcome in Multiple Sclerosis Patients Exposed to Disease Modifying Therapies Ahmed, Samar Farouk

37 C p.
artikel
94 Pregnancy Outcomes in Patients Treated with Ocrelizumab Oreja-Guevara, Celia

37 C p.
artikel
95 Preliminary Clinical Experience with Ocrelizumab, a New Recombinant Humanized Monoclonal Antibody for Multiple Sclerosis Baghestani, Ameneh A.

37 C p.
artikel
96 Prevalence and Incidence Rates of Multiple Sclerosis in Lebanon Zeineddine, Maya

37 C p.
artikel
97 Prevalence of Minor Beta Thalassemia (MBT) in Patients with Multiple Sclerosis (MS) in Southern Iran Nomovi, Masood

37 C p.
artikel
98 Prognostic Factors Stratification in Multiple Sclerosis Gharbi, Alya

37 C p.
artikel
99 Progressive Multifocal Myelopathy or Multiple Sclerosis? Lattanzi, Simona

37 C p.
artikel
100 Progressive sensorineural hearing loss many years preceding completion of Susac's syndrome triad: A case report Wang, Yujie

37 C p.
artikel
101 Reduction of Risk of Secondary Progressive Multiple Sclerosis Within Two Years of Treatment with Cladribine Tablets: An Analysis of the CLARITY Study Vermersch, Patrick

37 C p.
artikel
102 Response to commentary of Shirani and Okuda regarding "Unilateral arm rehabilitation for persons with multiple sclerosis using serious games in a virtual reality approach: Bilateral treatment effect?" Jonsdottir, J.

37 C p.
artikel
103 Risk Factors and Prevalence of Familial Multiple Sclerosis: A Population- Registry Based Study Eskandarieh, Sharareh

37 C p.
artikel
104 Rituximab associated necrosis: A case report Ashtari, Fereshteh

37 C p.
artikel
105 Rituximab is a Safe and Efficient Treatment in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Real World Observational Study Yazdanbakhsh, Sepideh

37 C p.
artikel
106 Routine Cognitive Processing Speed Assessment in Clinical Practice is Associated with Patient Reported Outcome, Employment, and Quantitative MRI Macaron, Gabrielle

37 C p.
artikel
107 Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis Alroughani, Raed

37 C p.
artikel
108 Second-Line Therapy in Multiple Sclerosis Ahmed, Mili

37 C p.
artikel
109 Sexual Dysfunction in Women with Early Multiple Sclerosis Abdo, Sarah

37 C p.
artikel
110 Study Fertility Characteristics in Female Patients with Neuromyelitis Optica Spectrum Disorder Heikal, Eman Salah

37 C p.
artikel
111 Subcortical structural abnormalities in female neuromyelitis optica patients with neuropathic pain Wang, Ting

37 C p.
artikel
112 Subcutaneous Interferon Beta-1a 22/44 mg Demonstrates Comparable Effectiveness Versus Teriflunomide in Newly Treated Patients with Multiple Sclerosis. a Study in a French Nationwide Cohort of Multiple Sclerosis: Observatoire Francais De La Sclérose En Pla Rollot, Fabien

37 C p.
artikel
113 Systematic Review of Environmental Risk Factors of Multiple Sclerosis in Middle East & North Africa Region Eskandarieh, Sharareh

37 C p.
artikel
114 Thalamic Involvement and its Impact on Disability and Cognition in Multiple Sclerosis: A Clinical and Diffusion Tensor Imaging Study Dahshan, Ahmed

37 C p.
artikel
115 The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review Marx, Wolfgang

37 C p.
artikel
116 The effect of galanin gene polymorphism rs948854 on the severity of multiple sclerosis: A significant association with the age of onset Lioudyno, Victoria

37 C p.
artikel
117 The First Arabic Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) Darwish, Hala

37 C p.
artikel
118 The Frequency of Anti-Aquaporin-4 Ig G Antibody and Oligodendrocyte Glycoprotein (MOG) in Neuromyelitis Optica Spectrum Disorders Hatem, Anmar Oday

37 C p.
artikel
119 The frequency of longitudinally extensive transverse myelitis in MS: A population-based study Asnafi, Solmaz

37 C p.
artikel
120 The multiple sclerosis gut microbiota: A systematic review Mirza, Ali

37 C p.
artikel
121 The Patterns of Clinical Presentation of Multiple Sclerosis in Patients Admitted to the National Center of Neurological Sciences, Khartoum, Sudan 2018 Ibrahim, Etedal Ahmed Abuelbasher

37 C p.
artikel
122 The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjects Milewska, Magdalena

37 C p.
artikel
123 The Prevalence of Familial Multiple Sclerosis in Shiraz, Southern Iran Dorche, Maryam Sharifian

37 C p.
artikel
124 The relation between memory and decision-making in multiple sclerosis patients Hoffmann, Janina A.

37 C p.
artikel
125 The Usability Evaluation of Web Base National Multiple Sclerosis (MS) Registry of Iran Mokhberdezfuli, Mahdieh

37 C p.
artikel
126 The Use Natalizumab in Multiple Sclerosis Patients During Pregnancy is Safe and Prevents Disease Reactivation Alroughani, Raed

37 C p.
artikel
127 TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis Ntellas, Panagiotis

37 C p.
artikel
128 Transient MOG antibody seroconversion associated with immunomodulating therapy Pawlitzki, Marc

37 C p.
artikel
129 Ultraviolet B Radiation Therapy Versus Vitamin D3 Supplementation: Effects on Cognitive Functions and Fatigue in Egyptian Relapsing Remitting Multiple Sclerosis Patients Elmazny, Alaa

37 C p.
artikel
130 Updated Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: Integrated Safety Analysis and Post-Approval Data Cook, Stuart

37 C p.
artikel
131 Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation Gmuca, Sabrina

37 C p.
artikel
132 1-Year Follow Up Efficacy of Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) Among Saudi Patients Heji, Alaa Talal

37 C p.
artikel
                             132 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland